Inspire Medical price target raised to $250 from $225 at Mizuho

Mizuho raised the firm’s price target on Inspire Medical to $250 from $225 and keeps a Buy rating on the shares. The company reported an in-line quarter versus its better than expected preannouncement and reiterated its initial guidance, the analyst tells investors in a research note. The firm still sees “some legs” for the shares ahead of the pivotal SURMOUNT-OSA study readout later this year.